Data / Drug companies / Terbutaline sulfate
Terbutaline sulfate: 10 companies and 17 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Terbutaline sulfate is listed in the FDA National Drug Code Directory by 10 companies, with 17 products in commercial distribution. 15 of the products (88.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection; injection, solution, and the newest product started marketing on January 12, 2022.
The request: Get every company that lists terbutaline sulfate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 17
- Generic (ANDA) products
- 15 (88.2%)
- Application numbers
- 6
- Routes
- Oral, Subcutaneous
- openFDA record search
- api.fda.gov
Companies that list terbutaline sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals of New York LLC | 2 | tablet | Generic drugs (ANDA) | June 26, 2001 |
| Ani Pharmaceuticals, Inc. | 2 | tablet | Authorized generics (NDA) | October 16, 2018 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | March 25, 2005 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection | Generic drugs (ANDA) | May 20, 2009 |
| Lannett Company, Inc. | 2 | tablet | Generic drugs (ANDA) | March 25, 2005 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | July 13, 2020 |
| Upsher-Smith Laboratories, LLC | 2 | tablet | Generic drugs (ANDA) | July 13, 2020 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | March 10, 2011 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | January 12, 2022 |
| Medical Purchasing Solutions, LLC | 1 | injection | Generic drugs (ANDA) | May 20, 2009 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 12 | 70.6% |
| Injection | 3 | 17.6% |
| Injection, solution | 2 | 11.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 15 | 88.2% |
| Authorized generics (NDA) | 2 | 11.8% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.